Avalon GloboCare Corp., a Delaware-based company, has entered into a significant securities purchase agreement with Brown Stone Capital Ltd., an accredited investor. Under the agreement, Avalon will issue and sell 121,200 shares of its common stock and pre-funded warrants for an additional 354,300 shares to the investor, totaling $475,500. The transaction, which closed on July 17, 2025, generated net proceeds of $450,500 for Avalon after deducting offering expenses. Additionally, Avalon and the investor have entered into a registration rights agreement, committing to register the shares and warrants under the Securities Act of 1933. Avalon aims to file the registration statement by September 26, 2025, and seeks SEC approval within thirty to seventy-five days, depending on the review process.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。